The Limits to Consumerism in Health Care: A Lecture by Mary Anne Bobinski
Couldn't attend the event? Check out some of our speakers' slide presentations!
Description
It is often said that health care has moved from paternalism, in the form of “doctor knows best,” to consumerism, in which patients expect to be able to obtain treatment consistent with their values and preferences. This presentation explored some of the limits to consumerism in health care, with a particular focus on circumstances where patient values or preferences conflict with provider values, professional ethics, or societal norms captured in legislation or court decisions. Considerable attention has been devoted to constraints on patient choice in areas such as abortion and end of life care. This presentation focused more broadly on the justifications and techniques for constraining patient choice in areas such as access to assisted reproductive technologies, risky therapies, pre-exposure prophylaxis for HIV, and extreme plastic surgery. Although the discussion focused on the U.S., selected examples from Australia, Canada, and the U.K. were also considered.
Speakers
Professor, Allard School of Law, University of British Columbia
Respondent: Louise P. King
Assistant Professor, Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Director of Reproductive Ethics, Center for Bioethics, Harvard Medical School; Surgeon, Division of Minimally Invasive Gynecologic Surgery, Beth Israel Deaconess Medical Center
This event was free and open to the public.
Learn More
Couldn't attend the event? Check out some of our speakers' slide presentations!
-
Mary Anne Bobinski, "The Limits to Consumerism in Health Care"
Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Center for Bioethics at Harvard Medical School, with support from the Oswald DeN. Cammann Fund.
Videos
VIDEO: Introduction, I. Glenn Cohen
Tags
abortion bioethics doctor patient relationship health law policy hivaids judicial opinions pharmaceuticals reproductive rights reproductive technologies